22 April 2017 MS News MS Trials Biotech company announces the completion of second clinical trial for novel progressive MS therapy
30 March 2017 MS News MS Trials FDA approves Ocrelizumab for Relapsing-remitting and Primary Progressive MS
7 December 2016 MS News MS Trials New study shows benefits of current treatments for people with advanced MS